Hilary Eaton, Ph.D., is the Chief Business Officer at ProFluent Bio, where she champions open-source AI gene editing tools. Once a skeptic of AI in drug discovery, her perspective shifted after personal and professional challenges. She delves into her transformative journey from molecular biology to business, the emotional strains of parenting a child with a rare disorder, and the critical role of genetics in therapeutic innovation. Hilary also discusses the importance of collaboration in advancing biotech through AI, emphasizing resilience and support in the industry.
